SCIEX delivers advanced technologies and software that contribute to the understanding and research of human disease. Decades of innovative LC/MS, LC/MS/MS and CE solutions enable scientists around the world to find deeper insights in discovery proteomics, targeted peptide quantitation, lipidomics, metabolomics, protein characterization and tissue imaging ― leading to advances in systems biology, biomarker discovery for disease management, and new drug discovery. Collaborating closely with our customers, SCIEX strives to exceed expectations and turn insights into answers that change lives. For information visit www.sciex.com/omics.
Waters Corporation creates business advantages for laboratory-dependent organizations by delivering scientific innovation to enable customers to make significant advancements. Waters helps customers make profound discoveries, optimize laboratory operations, deliver product performance, and ensure regulatory compliance with a connected portfolio of separations and analytical science, laboratory informatics, mass spectrometry, as well as thermal analysis.
Atlas Antibodies is a Swedish manufacturer and supplier with a mission to provide customers around the world with advanced research reagents targeting all human proteins. Currently Atlas Antibodies carries four brands: Triple A Polyclonals, PrecisA Monoclonals, PrEST Antigens and QPrEST Mass Spectrometry Standards. Characterization data for our antibodies can be found on our website as well as on the freely available Human Protein Atlas portal.
Atlas Antibodies, by researchers, for researchers.
Arrayjet provide instruments and services to pharma, diagnostic and lifescience industries. Our products use inkjet technology for precision picolitre liquid handling. Arrayjet focus on printing biological samples to create tools for genomic and proteomic screening, patient stratifi cation and clinical diagnosis.
Atturos is a new innovative diagnostics company founded specifically with the intention of bringing advanced molecular diagnostic tests to patient use and benefit. Atturos’ first product in development is a multiplexed blood protein test, OCProDx.
The OCProDx test will help to establish whether prostate cancer, once diagnosed, is confined to the prostate. A more informed post-diagnosis decision will lead to a reduction in unnecessary and over treatment of a disease that most patients die with rather than from. Atturos has a highly experienced and committed initial leadership team which has the support of a wide network of commercial, clinical and scientific advisors as well as patients.
Biametrics develops and markets label-free analytical system solutions for life science applications. Our patented label-free SCORE technology includes an innovative detection method, surface chemistry and assay development for time-resolved analysis of any kind of biomolecular interaction. We offer label-free measurement systems from single-channel devices up to high-throughput microarray readers. Together with leading peptide and protein manufacturers we develop specialized tools for multiple applications like autoimmune disease and cancer research or biologics screening.
Bioinformatics Solutions, Inc. is well known for its PEAKS software suite and service solutions for proteomics discovery and therapeutic protein characterization by mass spectrometry. Its benchmark de novo sequencing algorithm contributes advanced proteomic analyses by expanding the workflow in peptide/protein identification & quantification, peptide mapping, PTMs and sequence variants.
Biognosys is the leading proteomics company offering innovative services and products for highly multiplexed protein quantification. We are dedicated to transforming the life sciences with superior proteomics solutions. Biognosys’ mass spectrometry based next generation technology allows simultaneous quantification of thousands of proteins in a single experiment with unbeatable precision and depth. This new generation protein quantification technology is available to researchers through our contract research services or our portfolio of innovative reagent and software products.
Biotech Support Group develops methods for cost effective and efficient proteomic sample prep. Its consumable research products support the rapidly expanding installation of LC-MS instrument and computational infrastructure. For this market, key products include: AlbuVoid™ & AlbuSorb™ for albumin depletion, and HemogloBind™ & HemoVoid™ for hemoglobin removal. The company is now commercializing biomarker intellectual property assets that support Stroma Liquid Biopsy™, with special emphasis on early detection and personalized medical profiles for cancer. Through a co-marketing relationship with Array Bridge Inc, PEP technology – a top-down electrophoretic platform for activity-based functional proteomics research and biomarker discovery will also be displayed.
Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the manufacture of stable isotope-labeled compounds (13C, D, 15N, 17O, 18O) used for qualitative and quantitative, MS-based ‘omics applications. Key innovative products include ProteusQC™ (for QC and quantitation), Mouse Express® mouse feed and mouse tissue, 99% enriched amino acids, SILAC and SILAM reagents, Fmoc protected amino acids and preloaded resins (for peptide synthesis), dimethyl labeling reagents, 18O water (for enzymatic labeling), heavy labeled proteins, INLIGHT™ (for glycan tagging), heavy labeled glycans, and PeptiQuant™ MRM Assay Kits.
Diagenode is a leading provider of complete solutions for epigenetics research. The company has developed sonication technologies for sample preparation in chromatin proteomics. Diagenode offers innovative DNA and chromatin shearing (Bioruptor®) and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows, including epigenetics assay services. For more information about Diagenode, please visit the company’s website at www.diagenode.com
Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.
Elsevier is a world-leading provider of information solutions that help you make better decisions, deliver better care, and sometimes make groundbreaking discoveries in science, health, and technology.
Elsevier, the modern publishing company, was founded in 1880. It has evolved from a small Dutch publishing house devoted to classical scholarship into an international multimedia publishing company with over 20,000 products for educational and professional science and healthcare communities worldwide. Elsevier takes its name from the original House of Elzevir, a Dutch family publishing house founded in 1580.
Expedeon develops and manufactures reagents and instruments for genomics and proteomics research.
Expedeon supplies routine consumables with unique features
such as InstantBlueTM Coomassie stain and RunBlueTM precast
Bis-Tris protein gels, which are present in many laboratories and established in the scientific literature.
Additionally, we bring cutting-edge technologies and devices such as GelFree® for fractionation of whole proteomes. Expedeon aims to both support and advance proteomics research through developing and providing innovative products and technologies.
GL Sciences is a manufacturer of a huge range of products for HPLC, LC/MS, Ultra HPLC, samples preparation, and proteomics. It is a major HPLC consumables provider worldwide, especially known as the best manufacturer for the enrichment/purification of phosphopeptides, which our Titansphere Phos-TiO kit and bulk materials are widely used throughout the world. High Resolution capillary columns are available for the identification for Peptides/Proteins for Proteome Research.
hPOP is a HPP project studying variation in biological molecules in large population. Samples will be collected during HUPO conferences from attendees of the conference.
Two phases of the study have already been done in Boston (2016 US HUPO) and Taipei (2016 HUPO) and we are getting ready for Dublin HUPO.
Save the Date for HUPO 2018 in Orlando, Florida, USA! September 30-October 3, 2018.
HUPO 2018 congress organizers Joshua LaBaer (Biodesign Institute, Arizona State University), Ileana Cristea (Princeton University), Robert Moritz (Institute for Systems Biology), and John R. Yates III (The Scripps Research Institute) invite you to explore the wizardry of precision proteomics –where the sparks of biology and innovation fly. The conference venue is Loews Royal Pacific Hotel at Universal Studio. www.hupo2018.org
Join us for the 18th World Congress of the Human Proteome Organisation 2019!
HUPO 2019 promises to deliver an unsurpassed scientific program including outstanding international speakers at the very forefront of proteomics and associated fields, alongside an exceptional spotlight for students and early career researchers.
Held in the beautiful city of Adelaide, you will get a taste of Australia and enjoy its renowned wines, the cosmopolitan cuisine, the pristine surrounding nature, making HUPO 2019 a memorable experience!
We look forward to welcoming you to Adelaide on 14th- 19th September 2019.
INTAVIS is an international company offering instruments for complex procedures in life-science.
Our peptide synthesizers are well suited for parallel peptide synthesis for hundreds of peptides at low to high milligram scales. The SPOT technology allows synthesis of peptide arrays on membranes. For proteomic research INTAVIS offers the DigestPro MSi for in-gel and in-solution digestion and subsequent sample preparation techniques. Our service-lab offers custom peptides including stable isotopes, custom made SPOT- and CelluSpots peptide arrays.
MRM Proteomics Inc. is a proteomics technology company. We offer a wide variety of high quality services for protein quantitation, structural characterization, tissue imaging and a line of easy-to-use proteomics kits under the PeptiQuant brand name. We are also involved in developing clinical diagnostics. Although our portfolio of services fits with diverse applications, we recognize that research projects are not “one-size-fits-all.” Our unique expertise allows us to offer custom-tailored solutions for your specific research needs.
Swedish company Olink Proteomics provides innovative solutions for targeted human protein biomarker discovery, with rapid, high-throughput analysis, exceptional data quality and minimal sample consumption. Using our Proximity Extension Assay (PEA) technology, 1 µl of samples are analyzed for 92 biomarkers simultaneously, with exceptional readout specificity. Disease or biological process-focused panels are available, with full transparency on our rigorous validation data. Olink panels are available as ready-to-use kits or via our fee-for service offering.
PerkinElmer is a global leader focused on improving the health and safety of people and the environment. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain greater insights into their science to better protect our environment, our food supply and the health of our families.
Proteomes is an international, peer-reviewed, open access journal on all aspects of proteomic science, led (as the Editor-in-Chief) by Prof. Dr. Jacek R. Wisniewski from the Max-Planck-Institute for Biochemistry, Germany. The journal is indexed in the ESCI and citations are available in PubMed with full-text archived in PubMed Central. Proteomes provides a rigorous and efficient peer-review process for all manuscripts; first decision being offered to authors within approximately 29 days. Accepted manuscripts will then be published quickly online—within 7 days. The editorial staff of Proteomes are looking forward to collaborating with you to ensure your high quality research is disseminated quickly.
PharmaFluidics introduces the silicon revolution in chromatography. We supply µPAC® micro-Chip based chromatography columns for use in all standard nano-LC equipment. The perfect order of the micro-Chip Pillar Arrays overcomes the physical limits of any packed bed alternative. The revolutionary redesign of the HPLC separation bed reduces peak dispersion to an absolute minimum. PharmaFluidics’ µPAC® micro-Chip based chromatography columns allow to detect more molecules, with higher sensitivity, in tiny, complex biological samples, at low operating pressures. The µPAC® micro-Chip columns enhance the data productivity of many installed nano-LC/MS systems.
PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. We at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Our mission is to provide you with the best possible solutions and highest quality to achieve your results faster, easier and with better robustness than ever before.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology (“PCT”).
PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 90,000 psi) to safely, conveniently and reproducibly control the actions of molecules in biological samples, e.g., the rupture (lysis) of cells and tissues from human, animal, plant, and microbial sources, and the inactivation of pathogens.
is is a text block. Click the edit button to change this text.
ReSyn Biosciences aims to improve the reproducibility and automation of Mass Spectrometry and Bioseparation workflows by providing high capacity and specificity magnetic microparticles, developed using it’s proprietary polymer microparticle technology platform.
Sengenics is a functional proteomics and research and diagnostics company, with a
range of proprietary and patented technologies and products.
The main focus of the company is leveraging on our core patented Immunome
protein array technology for discovering antibody-based therapeutics and
diagnostic signatures for immune system disorders. The Immunome protein array
platform was originally developed as a collaboration between the University of
Oxford and the University of Cambridge, by Professor Jonathan Blackburn.
Silantes activities are focused on the production and marketing of compounds labelled with stable isotopes (SI: 2H, 13C and 15N ) used in NMR structural analysis and quantitative mass spectrometry. Silantes is specialized on SILAC/SILAM-products.
Silantes SI-platforms are:
– Heteronuclear NMR providing
– SI-labelled growth media for E.coli and yeast
– SI-labelled nucleotides (d/rNTP, NMPs)
– Quantitative proteomics providing:
– SI-amino acids
– kits for cell culture-labelling (SILAC)
– kits for in vivo-15N-labelling of SILAM-mouse
– kits for in vivo-13C-lys-labelling of SILAC-mouse, SILAC-fly, SILAC-zebrafish etc.
– Service for in vivo proteomics in mice
Synpeptide Co Ltd, Located in Shanghai, China, serves scientists and researchers around the world by providing high quality peptides, technical support and related services. Our team has built a substantial know-how in all areas of peptide applications ranging from biomarker discovery and immune monitoring to proteomics, vaccine and and drug development. Synpeptide’s monthly capacity reaches >10,000 purified custom peptides. Global market share has been over 30%.
Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Veritomyx® delivers unprecedented mass spectral analysis quality and completeness, through advanced signal processing and identification algorithms applied to raw MS data. PeakInvestigator® software differentiates peak signals from noise with statistical confidence intervals, and deconvolves overlapped peaks with 5-6x higher resolution, revealing critical hidden information. PeakInvestigator operates on raw profile MS data from ion trap, TOF, Orbitrap and FTICR mass analyzers. PeptideDetective® software (alpha collaborations phase), outperforms current market leaders in de novo peptide identifications. This more accurate and complete information helps to minimize inefficient misdirected R&D by accelerating metabolomic and proteomic biomolecular identifications.